TITLE

FDA increasing oversight of radiology

PUB. DATE
May 2010
SOURCE
Healthcare Risk Management;May2010, Vol. 32 Issue 5, p57
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the announcement of the Food and Drug Administration (FDA) wherein the oversights of the three most potent forms of medical radiation including computed tomography (CT) scans will be strengthen.
ACCESSION #
50354888

 

Related Articles

  • FDA Issues Final Guidance for Media Fills. Ritter, Amy // Pharmaceutical Technology;May2012, Vol. 36 Issue 5, p24 

    The article reports on the move of the U.S. Food and Drug Administration (FDA) in releasing a final guidance for preparing media fills for validation of aseptic preparations for positron emission tomography (PET) drugs.

  • What You Need to Know. Lewis, Carol // FDA Consumer;Nov/Dec2001, Vol. 35 Issue 6, p10 

    Presents information on computerized tomography (CT) scans. Uses of CT X-ray system approved by the U.S. Food and Drug Administration (FDA); Concerns of the FDA about CT screening; Mechanics of a CT scan.

  • Imaging agent designed to detect recurrent prostate cancer.  // Hem/Onc Today;10/10/2012, Vol. 13 Issue 19, p40 

    The article reports on the U.S. Food and Drug Administration (FDA) approval received by a positron emission tomography (PET) imaging agent designed to help detect recurrent prostate cancer.

  • Dual-Source CT Equipped With New Detector.  // Radiology Today;Aug2012, Vol. 13 Issue 8, p36 

    The article offers information on SOMATOM definition Flash dual source CT system with integrated stellar Detector from Siemens Healthcare.

  • CT problems magnified. Rhea, Shawn // Modern Healthcare;12/14/2009, Vol. 39 Issue 50, p10 

    The article focuses on the controversies surrounding the use of computed tomography (CT) perfusion brain scans. The U.S. Food and Drug Administration (FDA) argues that tighter guidelines and equipment standardization are needed to address concerns on the excessive amounts of radiation received...

  • Study finds no clinical consequences related to CT imaging of patients with cardiac rhythm devices.  // Cardiology Today;Apr2014, Vol. 17 Issue 4, p10 

    The article explores a study on importance of a 2008-issued U.S. Food and Drug Administration (FDA) advisory that recommended the presence of a physician to handle emergency measures during computed tomography (CT) imaging procedures, which concluded that CT imaging should not be canceled if a...

  • FDA clears database for OCT device.  // Ophthalmology Times;10/15/2010, Vol. 35 Issue 20, p27 

    The article reports on the permission given by the U.S. Food and Drug Administration to Optovue Inc. for a normative database for an optical coherence tomography (OCT) device.

  • FDA okays RTVue for calculating corneal power.  // Optometry Times;Nov/Dec2011, Vol. 3 Issue 10, p5 

    The article reports on the approval of the Food and Drug Administration (FDA) in the U.S. on the clearance of RTVue's optical coherence tomography (OCT) measurements of central corneal power.

  • 5 Medical Better-Health-Now Breakthroughs. Whitman, Stacy // Glamour;Nov99, Vol. 97 Issue 11, p69 

    Provides health-related information in the United States (US). Capabilities of low-dose computed tomography scans in identifying early-stage lung tumor among smokers; Description of the POCkit HSV-2 Rapid Test approved by the US Food and Drug Administration; Mechanism of action of Sonata, a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics